ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

NPCC Workshop Developed “Exciting List” Of Projects, Organizer Says

November 8, 1996

FDA Publishes Parallel Track Rules, Accelerated Drug Approval Initiative

April 25, 1992

Statins May Not Have Impact On Testosterone In The Blood

August 31, 2007

To Cut Colon Cancer Deaths, Reduce Barriers To Screening, NIH Panel Says

February 5, 2010

Prevention, Centers To Gain, some $$ In President’s Budget

February 8, 1991

NCI Cooperative Group Clinical Trials Approved

August 28, 2009